Recipharm named Vikas Gupta as President of its recently renamed biologics business arm. Gupta joins ReciBioPharm from Repligen, where he was Vice President & General Manager, Gene Therapy and Downstream Bioprocessing. The appointment comes as Recipharm officially renames its biologics business division after the acquisitions of Arranta Bio, GenIbet and Vibalogics.
1st Jan change | Capi. | |
---|---|---|
+5.86% | 71.05B | |
+23.95% | 9.03B | |
-22.81% | 4.38B | |
+14.83% | 4.27B | |
+19.21% | 3.73B | |
-0.82% | 1.99B | |
+8.78% | 1.96B | |
-36.94% | 1.87B | |
-45.25% | 1.71B |